Trials / Unknown
UnknownNCT02655198
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- KU Leuven · Academic / Other
- Sex
- All
- Age
- 3 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
In this trial, the potential anti-epileptic effect of low dose fenfluramine in Lennox Gastaut epilepsy will be studied. An exploratory dose finding add-on trial is proposed. At baseline and at the end of the study, ECG and ultrasound of the heart will be performed as part of the safety follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fenfluramine | study of efficacy and safety of add-on fenfluramine at different dosages in refractory Lennox Gastaut patients : 0.2 - 0.4 and 0.8 mg/kg/day (max 30 mg). |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-09-01
- Completion
- 2024-12-01
- First posted
- 2016-01-13
- Last updated
- 2023-09-22
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02655198. Inclusion in this directory is not an endorsement.